blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1204657

EP1204657 - PIPERIDINE AND PYRROLIDINE DERIVATIVES DISPLAYING NEURONAL ACTIVITY [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  17.09.2004
Database last updated on 22.01.2025
Most recent event   Tooltip17.09.2004Application deemed to be withdrawnpublished on 03.11.2004  [2004/45]
Applicant(s)For all designated states
Schering Aktiengesellschaft
13342 Berlin / DE
For all designated states
VERTEX PHARMACEUTICALS INCORPORATED
130 Waverly Street
Cambridge, MA 02139-4242 / US
[N/P]
Former [2002/20]For all designated states
SCHERING AKTIENGESELLSCHAFT
13342 Berlin / DE
For all designated states
VERTEX PHARMACEUTICALS INCORPORATED
130 Waverly Street
Cambridge, MA 02139-4242 / US
Inventor(s)01 / BRUMBY, Thomas
Lepslusstrasse 60
D-12163 Berlin / DE
02 / MCDONALD, Fiona
Mohrunger Allee 6B
D-14055 Berlin / DE
03 / SCHNEIDER, Herbert
Salzachstrasse 26
D-14129 Berlin / DE
 [2002/26]
Former [2002/20]01 / BRUMBY, Thomas
Lepslusstrasse 60
D-12163 Berlin / DE
02 / MCDONALD, Fiona
Mohrunger Allee 6B
D-14055 Berlin / DE
03 / SCHNEIDER, Herbert
Duisburger Strasse 20
D-10707 Berlin / DE
Representative(s)Pohlman, Sandra M., et al
df-mp Dörries Frank-Molnia & Pohlman
Patentanwälte Rechtsanwälte PartG mbB
Theatinerstrasse 16
80333 München / DE
[N/P]
Former [2002/20]Pohlman, Sandra M., et al
Dörries Frank-Molnia & Pohlman, Triftstrasse 13
80538 München / DE
Application number, filing date00957534.118.08.2000
[2002/20]
WO2000US22617
Priority number, dateDE199913970718.08.1999         Original published format: DE 19939707
US19990150568P25.08.1999         Original published format: US 150568 P
[2002/20]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0112622
Date:22.02.2001
Language:EN
[2001/08]
Type: A1 Application with search report 
No.:EP1204657
Date:15.05.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 22.02.2001 takes the place of the publication of the European patent application.
[2002/20]
Search report(s)International search report - published on:EP22.02.2001
ClassificationIPC:C07D401/12, C07D207/08, C07D401/06, C07D401/14, C07D207/09, C07D213/38, A61K31/4409, A61K31/4439, A61K31/40, A61P25/28
[2002/20]
CPC:
C07D207/08 (EP); A61P21/04 (EP); A61P25/00 (EP);
A61P25/02 (EP); A61P25/04 (EP); A61P25/14 (EP);
A61P25/16 (EP); A61P25/28 (EP); A61P41/00 (EP);
A61P43/00 (EP); C07D213/32 (EP); C07D213/38 (EP);
C07D401/06 (EP); C07D401/12 (EP); C07D401/14 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2002/20]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:PIPERIDINE- UND PYRROLIDINEDERIVATE MIT NEURONALER WIRKUNG[2002/20]
English:PIPERIDINE AND PYRROLIDINE DERIVATIVES DISPLAYING NEURONAL ACTIVITY[2002/20]
French:DERIVES DE PIPERIDINE ET DE PYRROLIDINE AYANT UNE ACTIVITE NEURONALE[2002/20]
Entry into regional phase15.02.2002National basic fee paid 
15.02.2002Designation fee(s) paid 
15.02.2002Examination fee paid 
Examination procedure08.03.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
15.02.2002Examination requested  [2002/20]
19.04.2002Amendment by applicant (claims and/or description)
28.08.2002Despatch of a communication from the examining division (Time limit: M06)
06.03.2003Reply to a communication from the examining division
20.03.2003Despatch of a communication from the examining division (Time limit: M04)
17.07.2003Reply to a communication from the examining division
17.12.2003Despatch of a communication from the examining division (Time limit: M04)
28.04.2004Application deemed to be withdrawn, date of legal effect  [2004/45]
04.06.2004Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2004/45]
Fees paidRenewal fee
12.07.2002Renewal fee patent year 03
18.07.2003Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO9807740  (SCHERING AG [DE]) [X] 1,3,5,8 * page 62, line 7 *;
 [PX]WO9962881  (GUILFORD PHARM INC [US], et al) [PX] 1,3,5,8 * example 73 *;
 [PX]WO9962880  (GUILFORD PHARM INC [US], et al) [PX] 1,3,5,8 * example 30 *;
 [DA]US5614547  (HAMILTON GREGORY S [US], et al) [DA] 1-3,5,8 * example 4 *;
 [DA]WO9640140  (GUILFORD PHARM INC [US], et al) [DA] 1-3,5,8 * example 98 *;
 [AD]WO9910340  (VERTEX PHARMA [US]) [AD] 1-3,5,8 * table 1, compound 17 table 2, compound 2 *;
 [A]WO9835675  (GUILFORD PHARM INC [US]) [A] 1-3,5,8 * table II, compounds 1-4 *;
 [X]WO9723508  (NOVO NORDISK AS [DK], et al) [X] 1-3,5,8 * page 190, line 1 - line 5 *;
 JPH02235862  [ ] (SAPPORO BREWERIES, et al);
 [X]FR2718443  (SYNTHELABO [FR]) [X] 1-3,5,8 * page 14; examples 8.1,8.1.2 *;
 [PX]WO9955688  (WARNER LAMBERT CO [US], et al) [PX] 1-3,5,8 * page 112, line 17 *;
 JPH09124675  [ ] (DAIKIN IND LTD);
 [X]WO9604274  (MERCK SHARP & DOHME [GB], et al) [X] 1-3,5,8 * page 51, line 9 - line 10 *;
 [X]EP0337637  (SANKYO CO [JP]) [X] 1-3,5,8 * page 102, line 41 *
 [A]  - HAMILTON G S, "IMMUNOPHILIN LIGANDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS", EXPERT OPINION ON THERAPEUTIC PATENTS,GB,ASHLEY PUBLICATIONS, (1998), vol. 8, no. 9, ISSN 1354-3776, pages 1109 - 1124, XP000852684 [A] 1-3,5,8 * the whole document *

DOI:   http://dx.doi.org/10.1517/13543776.8.9.1109
 [X]  - ACHINAMI, KAZUO ET AL, "Preparation of pyrrolidines and their use as pharmaceuticals", CHEMABS, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 114:143131, URL: STN, XP002155300 [X] 1-3,5,8 *CAS RN 133946-59-5: 3-[2-[[[1-[(Heptyloxy)carbonyl]-2-pyrrolidinyl]methyl]thio]ethyl]thiazolium chloride* *CAS RN 122865-25-2: 3-[2-[[[1-(Ethoxycarbonyl)-2-pyrrolidinyl]methyl]thio]ethyl]thiazolium chloride*
 [X]  - IZEKI, KATSUHIKO ET AL, "Preparation of chiral bicyclophosphoramides as catalysts for asymmetric synthesis", CHEMABS, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 127:50791, URL: STN, XP002155301 [X] 1-3 *CAS RN 177948-62-8: 2-[[Methyl(phenylmethyl)amino]methyl]-1-pyrrolidinecarboxylic acid 1,1-dimethylethylester* *CAS RN 191231-61-5: 2-[[(Phenylmethyl)amino]methyl]-1-pyrrolidinecarboxylic acid 1,1-dimethylethyl ester*
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.